NCT00149383View on ClinicalTrials.gov

Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

November 30, 2005

Study Completion Date

January 31, 2006

Conditions
Falciparum Malaria
Interventions
DRUG

Rosiglitazone

DRUG

Placebo

Trial Locations (1)

10400

Faculty of Tropical Medicine, Mahidol University, Bangkok

All Listed Sponsors
collaborator

McLaughlin-Rotman Center for Global Health, University of Toronto

OTHER

lead

Mahidol University

OTHER

NCT00149383 - Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria | Biotech Hunter | Biotech Hunter